The Presence of Scarring and Associated Morbidity in the Burn Model System National Database.


Journal

Annals of plastic surgery
ISSN: 1536-3708
Titre abrégé: Ann Plast Surg
Pays: United States
ID NLM: 7805336

Informations de publication

Date de publication:
03 2019
Historique:
entrez: 7 2 2019
pubmed: 7 2 2019
medline: 19 5 2020
Statut: ppublish

Résumé

Postburn scarring is common, but the risk factors, natural history, and consequences of such scars are still poorly understood. This study aims to describe the frequency of scar-related morbidity for up to 2 years after injury and to analyze the impact of burn scars on long-term functional, psychosocial, and reintegration outcomes. Analysis was conducted on data collected between January 2006 and May 2014 from 960 patients (2440 anatomic burn sites) using the Burn Model System (BMS) database. Study population demographics were analyzed and odds ratios for the development of raised or thick scarring were determined. Regression analyses were used to evaluate the impact of hypertrophic scarring (HTS) on psychosocial outcomes, including the Community Integration Questionnaire, Satisfaction with Life Scale, Distress, and the Short Form 12. Symptoms associated with scarring were analyzed at discharge and 6, 12, and 24 months after burn using a set of questions on scarring developed by the BMS. Mixed-effect modeling was used to determine linear change over time and the significance of symptoms. The study population was primarily white (65.0%) and male (71.8%), with a mean (SD) age of 44.0 (15.2) years and mean total body surface area burned of 19.6% (17.9%). The incidence of raised or thick scars increased from 65% to 80% (P < 0.0001) for the 2-year follow-up period. The presence of scarring was not associated with Community Integration Questionnaire, Satisfaction with Life Scale, or Short Form 12 scores. Most patients reported symptoms associated with scarring at 2 years after burn, including dry or fragile skin, scars that restrict range of motion at a joint, issues with hand function, and scar pain and itch. In this large, longitudinal, multicenter cohort of burn survivors, nearly all patients noted the presence of scarring, and a majority noted additional symptoms and morbidity related to their scars even at 2 years after injury. This study demonstrates a need for the continued support of burn survivors to address scar-related morbidity. Furthermore, future studies examining the impact of novel treatments for scarring should use similar scar problem questionnaires and distress scores.

Identifiants

pubmed: 30724824
doi: 10.1097/SAP.0000000000001826
pii: 00000637-201903002-00005
pmc: PMC9201561
mid: NIHMS1812472
doi:

Types de publication

Journal Article Multicenter Study Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

S162-S168

Subventions

Organisme : ACL HHS
ID : 90DP0035
Pays : United States

Références

J Trauma. 1983 Oct;23(10):895-8
pubmed: 6632013
J Burn Care Res. 2007 Jul-Aug;28(4):598-601
pubmed: 17665521
Ann Surg. 2015 Feb;261(2):263-8
pubmed: 24670865
Wound Repair Regen. 2012 Sep-Oct;20(5):676-87
pubmed: 22985039
Br J Surg. 2001 Apr;88(4):583-7
pubmed: 11298629
Arch Facial Plast Surg. 2008 Mar-Apr;10(2):93-102
pubmed: 18347236
J Burn Care Res. 2017 Jan/Feb;38(1):e192-e199
pubmed: 27355656
J Burn Care Rehabil. 2004 Jan-Feb;25(1):25-32
pubmed: 14726736
Ann Surg. 2015 Oct;262(4):563-9
pubmed: 26366535
J Burn Care Res. 2016 Mar-Apr;37(2):106-14
pubmed: 26536539
N Engl J Med. 1998 Feb 5;338(6):362-6
pubmed: 9449729
Burns. 2003 Jun;29(4):299-302
pubmed: 12781605
J Burn Care Res. 2007 Jan-Feb;28(1):84-96
pubmed: 17211206
J Burn Care Res. 2017 Jan/Feb;38(1):e328-e336
pubmed: 27380122
J Burn Care Res. 2012 Jan-Feb;33(1):136-46
pubmed: 22138807

Auteurs

Waverley He (W)

Harvard Medical School.

Geoffrey Martello (G)

Harvard Medical School.

Ann Whalen (A)

Harvard Medical School.

Edward Bittner (E)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA.

Nicole Gibran (N)

Department of Surgery, University of Washington, Seattle, WA.

David Herndon (D)

University of Texas Medical Branch, Shriners Hospital for Children-Galveston, Galveston, TX.

Oscar Suman (O)

University of Texas Medical Branch, Shriners Hospital for Children-Galveston, Galveston, TX.

Karen Kowalske (K)

University of Texas Southwestern Medical Center, Dallas.

Walter J Meyer (WJ)

University of Texas Medical Branch, Shriners Hospital for Children-Galveston, Galveston, TX.

Jeffrey Schneider (J)

Spaulding Rehabilitation Hospital/Harvard Medical School, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH